Kits Eyecare Stock Beta
| KITS Stock | CAD 9.19 0.34 3.84% |
Kits Eyecare fundamentals help investors to digest information that contributes to Kits Eyecare's financial success or failures. It also enables traders to predict the movement of Kits Stock. The fundamental analysis module provides a way to measure Kits Eyecare's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kits Eyecare stock.
Kits | Beta |
Kits Eyecare Company Beta Analysis
Kits Eyecare's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current Kits Eyecare Beta | 0.36 |
Most of Kits Eyecare's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kits Eyecare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Kits Beta Driver Correlations
Understanding the fundamental principles of building solid financial models for Kits Eyecare is extremely important. It helps to project a fair market value of Kits Stock properly, considering its historical fundamentals such as Beta. Since Kits Eyecare's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Kits Eyecare's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Kits Eyecare's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, Kits Eyecare has a Beta of 0.356. This is 57.62% lower than that of the Specialty Retail sector and 73.63% lower than that of the Consumer Discretionary industry. The beta for all Canada stocks is notably lower than that of the firm.
Kits Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kits Eyecare's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kits Eyecare could also be used in its relative valuation, which is a method of valuing Kits Eyecare by comparing valuation metrics of similar companies.Kits Eyecare is currently under evaluation in beta category among its peers.
As returns on the market increase, Kits Eyecare's returns are expected to increase less than the market. However, during the bear market, the loss of holding Kits Eyecare is expected to be smaller as well.
Kits Fundamentals
| Return On Equity | -0.002 | |||
| Return On Asset | 0.0039 | |||
| Profit Margin | (0.0007) % | |||
| Operating Margin | 0.02 % | |||
| Current Valuation | 283.99 M | |||
| Shares Outstanding | 31.58 M | |||
| Shares Owned By Insiders | 75.76 % | |||
| Shares Owned By Institutions | 4.19 % | |||
| Number Of Shares Shorted | 9.08 K | |||
| Price To Book | 5.44 X | |||
| Price To Sales | 1.99 X | |||
| Revenue | 120.51 M | |||
| Gross Profit | 29.25 M | |||
| EBITDA | 2.34 M | |||
| Net Income | (2.21 M) | |||
| Cash And Equivalents | 18.79 M | |||
| Cash Per Share | 0.60 X | |||
| Total Debt | 15.39 M | |||
| Debt To Equity | 0.40 % | |||
| Current Ratio | 1.80 X | |||
| Book Value Per Share | 1.69 X | |||
| Cash Flow From Operations | 2.4 M | |||
| Short Ratio | 0.12 X | |||
| Earnings Per Share | (0.01) X | |||
| Target Price | 15.5 | |||
| Number Of Employees | 143 | |||
| Beta | 0.36 | |||
| Market Capitalization | 290.19 M | |||
| Total Asset | 87.64 M | |||
| Retained Earnings | (27.91 M) | |||
| Working Capital | 9.46 M | |||
| Net Asset | 87.64 M |
About Kits Eyecare Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kits Eyecare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kits Eyecare using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kits Eyecare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Other Information on Investing in Kits Stock
Kits Eyecare financial ratios help investors to determine whether Kits Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kits with respect to the benefits of owning Kits Eyecare security.